《大行報告》瑞信下調高鑫零售(06808.HK)目標價至4元 評級「中性」
瑞信發表報告,指高鑫零售(06808.HK)上半年業績遜預期,收入和純利分別按年下降5%和86%。至於同店銷售下降7.4%,管理層預計2022年下半年的利潤將因更好的季節性因素而較上半年有所改善,但渠道組合的變化和潛在的減值及撥備可能會繼續影響公司復甦和利潤率。
報告指,激烈的行業競爭造成的壓力近期依然存在,而高鑫零售和阿裏巴巴(09988.HK)的長期協同效應帶來的上升空間需時反映,將2022/2023/2024財年每股盈利預測分別下調67%/22%/17%,目標價相應由5元下調至4元,維持評級「中性」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.